Industry experts talk with PharmTech, Pharmaceutical Commerce, Applied Clinical Trials, and Pharmaceutical Executive about FDA's CNPV pilot program.
Andy Studna
Advertisement
Andy Studna is a senior editor for Pharmaceutical Executive and Applied Clinical Trials. He can be reached at [email protected].
Articles by Andy Studna
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
FDA Duloxetine Recall Highlights Generic Manufacturing Quality Gaps
2
Germany Pharma Tariff Threat: What Manufacturers Need to Know
3
Why the First Generic Single-Dose Flu Antiviral Approval Matters
4
PharmTech Weekly Roundup—June 19, 2026
5